EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Dietary Restriction of Advanced Glycation End-Products (AGEs) in Patients with Diabetes: A Systematic Review of Randomized Controlled Trials

Paraskevi Detopoulou iD, Gavriela Voulgaridou, Vasiliki Seva, Odysseas Kounetakis, Ios-Ioanna Desli iD, Despoina Tsoumana, Vasilios Dedes iD, Evridiki Papachristou, Sousana Papadopoulou iD, George Panoutsopoulos

International Journal of Molecular Sciences · 23.10.2024 · 25 (21) · 11407

DOI: 10.3390/ijms252111407 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.10.2024. Verfasst von Paraskevi Detopoulou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutritional Sciences and Dietetics, University of the Peloponnese, 24100 Kalamata, Greece. Hauptthemen laut MEDLINE: Glycation End Products, Advanced. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advanced Glycation End Products (AGEs) are formed through non-enzymatic reactions between reducing sugars and proteins, nucleic acids or lipids (for example through hyperoxidation). In diabetes, elevated glucose levels provide more substrate for AGEs formation. AGEs can also be ingested through the diet from foods cooked at high temperatures, or containing much sugar. The present work aimed to review all published randomized controlled trials (RCT) on low-dietary AGE (L-dAGEs) interventions in patients with diabetes. Pubmed, Scopus and Cochrane databases were searched (until 29 February 2024) with appropriate keywords (inclusion criteria: RCT, patients with diabetes, age > 18 years, outcomes related to inflammation, glucose, and lipids; exclusion criteria: non-RCTs, case-series, case reports and Letter to the Editor, or animal studies). The present review was registered to the Open Science Framework (OSF). From 7091 studies, seven were ultimately included. Bias was assessed with the updated Cochrane Risk of Bias tool. A reduction in circulating AGEs was documented in 3/3 studies. No particular differences were documented in glycemic parameters after a L-dAGEs diet. Reductions in glucose levels were observed in one out of six studies (1/6), while HbA1c and HOMA did not change in any study (0/6 and 0/3, correspondingly). Lipid profile also changed in one out of four studies (1/4). More consistent results were observed for oxidative stress (beneficial effects in 3/3 studies) and inflammatory markers (beneficial effects in 4/4 studies). Other athero-protective effects, such as adiponectin increases, were reported. Limitations included the small sample size and the fact that dietary and physical activity habits were not considered in most studies. In conclusion, a L-dAGEs pattern may minimize AGEs accumulation and have beneficial effects on oxidative stress and inflammation indices, while its effects on glycemic and lipemic parameters are inconsistent and modest in patients with diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycation End Products, AdvancedHumansBlood GlucoseDiabetes MellitusDietRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

advanced glycation end-productsdiabetesdietdietary intervention

Substanzen

Blood GlucoseGlycation End Products, Advanced

Autor:innen und Institutionen

  • Department of Nutritional Sciences and Dietetics, University of the Peloponnese, 24100 Kalamata, Greece.
  • Department of Clinical Nutrition, General Hospital Korgialenio Benakio, 11526 Athens, Greece.
  • Department of Nutritional Sciences and Dietetics, School of Health Sciences, International Hellenic University, 57400 Thessaloniki, Greece.

ORCID-Profile: Paraskevi Detopoulou, Ios-Ioanna Desli, Vasilios Dedes, Sousana Papadopoulou

Zitieren

APA

Detopoulou, P., Voulgaridou, G., Seva, V., Kounetakis, O., Desli, I. I., Tsoumana, D., Dedes, V., Papachristou, E., Papadopoulou, S., & Panoutsopoulos, G. (2024). Dietary Restriction of Advanced Glycation End-Products (AGEs) in Patients with Diabetes: A Systematic Review of Randomized Controlled Trials. International Journal of Molecular Sciences, 25(21), 11407. https://doi.org/10.3390/ijms252111407

Vancouver

Detopoulou P, Voulgaridou G, Seva V, Kounetakis O, Desli II, Tsoumana D, et al. Dietary Restriction of Advanced Glycation End-Products (AGEs) in Patients with Diabetes: A Systematic Review of Randomized Controlled Trials. International Journal of Molecular Sciences. 2024;25(21):11407. doi:10.3390/ijms252111407

BibTeX
@article{Detopoulou2024,
  author = {Detopoulou, Paraskevi and Voulgaridou, Gavriela and Seva, Vasiliki and Kounetakis, Odysseas and Desli, Ios-Ioanna and Tsoumana, Despoina and Dedes, Vasilios and Papachristou, Evridiki and Papadopoulou, Sousana and Panoutsopoulos, George},
  title = {Dietary Restriction of Advanced Glycation End-Products (AGEs) in Patients with Diabetes: A Systematic Review of Randomized Controlled Trials},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {21},
  pages = {11407},
  doi = {10.3390/ijms252111407}
}
Kostenlos starten →